Skip to content
★ Sign in to follow
XB

Xuanzhu Biopharmaceutical Co., Ltd. - B - H Shares Stock: price and insider trades · Hong Kong

HK·Mcap HK$4.3B

Xuanzhu Biopharmaceutical Co., Ltd. - B - H Shares: what insiders have been doing

Xuanzhu Biopharmaceutical Co., Ltd. - B - H Shares is a listed company. Its insiders report their share dealings to HKEX. The last twelve months, up to 8 November 2026, brought 3 filings signed by 3 insiders.

All open-market trades in the period are sales: 3 sales, by 3 insiders, with no purchase on record. No amount is published for 3 filings, which the totals therefore leave out.

Across the 1,323 companies tracked on its exchange, the median is 4 filings; at 3 filings, this issuer sits below that mark. Our records for Xuanzhu Biopharmaceutical Co., Ltd. - B - H Shares go back to 2026, with no purchases and 3 sales on the open market in total.

Filings reach the HKEX feed a median of 5 days after the trade. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
3 ops. · all time

Who traded when

BuySale
Li Jia Kui1 sale
Shih Cheng-Kon1 sale
Xu Yanjun1 sale
Fundamental score
Ranked 20,095 of 26,897 companies
34.7
score / 100
Value
21
Quality
48
FCF yld-5.8%
Earn yld-5.7%
EV/EBITDA·
ROE-20%
Gross mgn64%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$8.37
Analyst consensus
·
Income statement
RevenueHK$51.8M
Gross profitHK$33.4M64% margin
EBITDA-HK$215.3M-416% margin
Net income-HK$245.5M-203.2% margin
Valuation
P/Book2.8x
Balance sheet & cash
Market capHK$4.3B
Total debtHK$647k
Free Cash Flow-HK$252.5M
Debt / Equity0%
Profitability & ownership
ROE-19.6%
ROA-9.7%
% insiders80.8%
% institutions1.6%
Last declaration on 18 May 2026
Declarations3 total
  • ▼
    DirectorExecutives
    0HKEX
    3,020,800 sharesShareXHKGHKEX:DA20260515E00494
  • ▼
    DirectorExecutives
    0HKEX
    13,180,910 sharesShareXHKGHKEX:DA20260515E00503
  • ▼
    DirectorExecutives
    0HKEX
    1,700,000 sharesShareXHKGHKEX:DA20260515E00501

3 of 3 declarations

About Xuanzhu Biopharmaceutical Co., Ltd. - B - H Shares

Xuanzhu Biopharmaceutical Co., Ltd. is a company focused on the development and manufacturing of biopharmaceutical products. It is listed under the B - H Shares category.